Lymphocytes lacking IκB-α develop normally, but have selective defects in proliferation and function

Journal of Immunology

Volumn 165, Issue 10, 2000, Pages 5418-5427

  Chen, C L ^a   Singh, N ^a   Yull, F E ^a   Strayhorn, D ^a   Van Kaer, L ^a   Kerr, L D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; EMBRYO; FETUS LIVER; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034670001     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.10.5418     Document Type: Article

References (45)

1. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
2. Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein
3. Signal-induced degradation of IκBα requires site-specific ubiquitination
4. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB
5. Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel
6. Dif, a dorsal-related gene that mediates an immune response in Drosophila
7. Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila
8. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
9. Rel/NF-κB/IκB family: Intimate tales of association and dissociation
10. Regulation of immune responses by NF-κB/Rel transcription factor
11. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice
12. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice
13. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
14. Immunological defects in mice with a targeted disruption in Bcl-3
15. Cutting edge: Activation of NK T cells by CDId and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
16. Relationship of germinal centers in lymphoid tissue to immunologic memory. VI. Transfer of B cell memory with lymph node cells fractionated according to their receptors for peanut agglutinin
17. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation
18. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells
19. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
20. NF-κB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses
21. Germinal centers: A second childhood for lymphocytes
22. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation
23. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB
24. An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets
25. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-κB1) but expressing p50
26. Inhibition of TNF-induced apoptosis by NF-κB
27. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
28. Corepression of RelA and c-rel inhibits immunoglobulin κ gene transcription and rearrangement in precursor B lymphocytes
29. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB
30. The proto-oncogene bcl-3 encodes an IκB protein
31. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition
32. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers
33. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers
34. Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice
35. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
36. Requirement for NF-[κ]B in osteoclast and B-cell development
37. Immune and inflammatory responses in TNF-α-deficient mice: A critical requirement for TNF α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
38. The sequential role of lymphotoxin and B cells in the development of splenic follicles
39. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation
40. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion
41. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2
42. Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: Cooperative effects of cytokines
43. The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent
44. Arrest of B lymphocyte terminal differentiation by CD40 signaling: Mechanism for lack of antibody-secreting cells in germinal centers